These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Bisphosphonate-related osteonecrosis of the jaw complicated with wrist scaphoid osteomyelitis: a case report].
    Author: Sun ZW, Li ZY, Yu D, Zhu JY, Zhang YD, Zhu XM.
    Journal: Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Apr 01; 37(2):224-228. PubMed ID: 31168992.
    Abstract:
    Bisphosphonates can directly inhibit osteoclasts, which may lead to increased bone density, reduced blood flow, and osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis is usually observed in the jaw bone. In this article, we report a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) complicated with wrist scaphoid osteomyelitis. Furthermore, we introduce the pathogenesis, treatment, and prevention of BRONJ. 双膦酸盐类药物可以抑制破骨细胞功能，使颌骨骨密度升高，血流减少，发生骨坏死。双膦酸盐类药物相关性骨坏死多发于颌骨。本文报道1例双膦酸盐相关性颌骨坏死并发腕部舟状骨骨髓炎，并结合文献讨论双膦酸盐药物性颌骨坏死的发病机制、治疗与预防等。.
    [Abstract] [Full Text] [Related] [New Search]